Theranostics 2023; 13(13):4412-4429. doi:10.7150/thno.85084 This issue Cite

Research Paper

Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer

Yu-Yuan Wu1,2, Ya-Ling Hsu2,3,*,✉, Yung-Chi Huang2, Yue-Chiu Su4, Kuan-Li Wu2,3,5,6, Chao-Yuan Chang7, Chai-Tung Ong2,8, Jia-Chen Lai2, Tzu-Yen Shen9, Tai-Huang Lee5,10, Jen-Yu Hung1,5,10, Ying-Ming Tsai1,3,5,*,✉

1. School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
2. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
3. Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
4. Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
5. Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
6. Post Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
7. Department of Anatomy, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
8. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
9. School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
10. Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 807, Taiwan.
* Contributed equally.

Citation:
Wu YY, Hsu YL, Huang YC, Su YC, Wu KL, Chang CY, Ong CT, Lai JC, Shen TY, Lee TH, Hung JY, Tsai YM. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer. Theranostics 2023; 13(13):4412-4429. doi:10.7150/thno.85084. https://www.thno.org/v13p4412.htm
Other styles

File import instruction

Abstract

Graphic abstract

Background: Lung cancer is associated with a high mortality rate and often complicated with malignant pleural effusion (MPE), which has a very poor clinical outcome with a short life expectancy. However, our understanding of cell-specific mechanisms underlying the pathobiology of pleural metastasis remains incomplete.

Methods: We analyzed single-cell transcriptomes of cells in pleural effusion collected from patients with lung cancer and congestive heart failure (as a control), respectively. Soluble and complement factors were measured using a multiplex cytokine bead assay. The role of ferroptosis was evaluated by GPX4 small interfering RNA (siRNA) transfection and overexpression.

Results: We found that the mesothelial-mesenchymal transition (MesoMT) of the pleural mesothelial cells contributed to pleural metastasis, which was validated by lung cancer/mesothelial cell co-culture experiments. The ferroptosis resistance that protected cancer from death which was secondary to extracellular matrix detachment was critical for pleural metastasis. We found a universal presence of immune-suppressive lipid-associated tumor-associated macrophages (LA-TAMs) with complement cascade alteration in the MPE of the lung cancer patients. Specifically, upregulated complement factors were also found in the MPE, and C5 was associated with poor overall survival in the lung cancer patients with epidermal growth factor receptor mutation. Plasmacytoid dendritic cells (pDCs) exhibited a dysfunctional phenotype and pro-tumorigenic feature in the primary cancer. High expression of the gene set extracted from pDCs was associated with a poor prognosis in the lung cancer patients. Receptor-ligand interaction analysis revealed that the pleural metastatic niche was aggravated by cross-talk between mesothelial cells-cancer cells/immune cells via TNC and ICAM1.

Conclusions: Taken together, our results highlight cell-specific mechanisms involved in the pathobiological development of pleural metastasis in lung cancer. These results provide a large-scale and high-dimensional characterization of the pleural microenvironment and offer a useful resource for the future development of therapeutic drugs in lung cancer.

Keywords: Pleural metastasis, complement factor, mesothelial cell, lung cancer, ferroptosis


Citation styles

APA
Wu, Y.Y., Hsu, Y.L., Huang, Y.C., Su, Y.C., Wu, K.L., Chang, C.Y., Ong, C.T., Lai, J.C., Shen, T.Y., Lee, T.H., Hung, J.Y., Tsai, Y.M. (2023). Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer. Theranostics, 13(13), 4412-4429. https://doi.org/10.7150/thno.85084.

ACS
Wu, Y.Y.; Hsu, Y.L.; Huang, Y.C.; Su, Y.C.; Wu, K.L.; Chang, C.Y.; Ong, C.T.; Lai, J.C.; Shen, T.Y.; Lee, T.H.; Hung, J.Y.; Tsai, Y.M. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer. Theranostics 2023, 13 (13), 4412-4429. DOI: 10.7150/thno.85084.

NLM
Wu YY, Hsu YL, Huang YC, Su YC, Wu KL, Chang CY, Ong CT, Lai JC, Shen TY, Lee TH, Hung JY, Tsai YM. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer. Theranostics 2023; 13(13):4412-4429. doi:10.7150/thno.85084. https://www.thno.org/v13p4412.htm

CSE
Wu YY, Hsu YL, Huang YC, Su YC, Wu KL, Chang CY, Ong CT, Lai JC, Shen TY, Lee TH, Hung JY, Tsai YM. 2023. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer. Theranostics. 13(13):4412-4429.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image